{"id":6969,"date":"2026-04-07T15:03:23","date_gmt":"2026-04-07T15:03:23","guid":{"rendered":"https:\/\/www.rock-n-data.io\/?p=6969"},"modified":"2026-04-07T15:03:31","modified_gmt":"2026-04-07T15:03:31","slug":"scpi-comete-premier-actif-life-sciences-aux-pays-bas","status":"publish","type":"post","link":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/","title":{"rendered":"SCPI Com\u00e8te : premier actif Life Sciences aux Pays-Bas"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\"><strong>Une premi\u00e8re acquisition strat\u00e9gique pour la SCPI Com\u00e8te<\/strong><\/h2>\n\n\n\n<p>La <strong><a href=\"https:\/\/www.meilleurescpi.com\/scpi\/scpi-de-rendement\/f11523-scpi-comete\/\">SCPI Com\u00e8te<\/a><\/strong>, g\u00e9r\u00e9e par Alderan, franchit une \u00e9tape importante dans son d\u00e9veloppement avec l\u2019acquisition de son premier actif de typologie <strong>Life Sciences<\/strong>. Situ\u00e9 \u00e0 proximit\u00e9 imm\u00e9diate de Rotterdam, cet immeuble illustre une volont\u00e9 claire de diversification sectorielle et g\u00e9ographique.<\/p>\n\n\n\n<p>Cette op\u00e9ration s\u2019inscrit dans une strat\u00e9gie d\u2019investissement visant \u00e0 capter des opportunit\u00e9s dans des segments immobiliers porteurs, notamment celui des <strong>sciences de la vie<\/strong>, un secteur en pleine expansion en Europe.<\/p>\n\n\n\n<p>Avec une surface totale de <strong>10 228 m\u00b2<\/strong>, cet actif b\u00e9n\u00e9ficie d\u2019un emplacement consid\u00e9r\u00e9 comme <strong>prime<\/strong>, \u00e0 proximit\u00e9 d\u2019un p\u00f4le \u00e9conomique dynamique et d\u2019infrastructures de premier plan.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Pourquoi les Life Sciences attirent les SCPI ?<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Un secteur en forte croissance<\/strong><\/h3>\n\n\n\n<p>Le march\u00e9 des <strong>Life Sciences<\/strong> regroupe les activit\u00e9s li\u00e9es \u00e0 la <strong>biotechnologie<\/strong>, \u00e0 la <strong>pharmaceutique<\/strong>, \u00e0 la <strong>recherche m\u00e9dicale<\/strong> et aux technologies associ\u00e9es. Ce segment immobilier attire de plus en plus d\u2019investisseurs institutionnels en raison de plusieurs facteurs :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Une <strong>demande structurelle \u00e9lev\u00e9e<\/strong> li\u00e9e aux besoins en recherche et innovation<\/li>\n\n\n\n<li>Des locataires souvent solides, issus de groupes internationaux<\/li>\n\n\n\n<li>Des baux g\u00e9n\u00e9ralement <strong>longue dur\u00e9e<\/strong>, apportant de la visibilit\u00e9 sur les revenus locatifs<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Une diversification recherch\u00e9e<\/strong><\/h3>\n\n\n\n<p>Pour une SCPI, investir dans ce type d\u2019actif permet de :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>R\u00e9duire la d\u00e9pendance aux bureaux traditionnels<\/li>\n\n\n\n<li>Acc\u00e9der \u00e0 des march\u00e9s plus sp\u00e9cialis\u00e9s<\/li>\n\n\n\n<li>Renforcer la <strong>r\u00e9silience du portefeuille immobilier<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Caract\u00e9ristiques cl\u00e9s de l\u2019actif acquis<\/strong><\/h2>\n\n\n\n<p>L\u2019op\u00e9ration r\u00e9alis\u00e9e par la SCPI Com\u00e8te pr\u00e9sente plusieurs \u00e9l\u00e9ments structurants qui m\u00e9ritent une attention particuli\u00e8re.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Donn\u00e9es principales de l\u2019acquisition<\/strong><\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td class=\"has-text-align-center\" data-align=\"center\"><strong>\u00c9l\u00e9ments<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>D\u00e9tails<\/strong><\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Typologie<\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Life Sciences<\/strong><\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Localisation<\/td><td class=\"has-text-align-center\" data-align=\"center\">Proximit\u00e9 de Rotterdam (Pays-Bas)<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Surface<\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>10 228 m\u00b2<\/strong><\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Taux d\u2019occupation<\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>100 %<\/strong><\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Nombre de locataires<\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Monolocataire<\/strong><\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Date d\u2019acquisition<\/td><td class=\"has-text-align-center\" data-align=\"center\">2 avril 2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Un locataire strat\u00e9gique<\/strong><\/h3>\n\n\n\n<p>L\u2019actif est occup\u00e9 par un <strong>locataire unique<\/strong>, pr\u00e9sent\u00e9 comme un <strong>leader dans son domaine<\/strong>, engag\u00e9 via un bail de longue dur\u00e9e. Ce type de configuration peut permettre :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Une stabilit\u00e9 des revenus locatifs<\/strong><\/li>\n\n\n\n<li><strong>Une simplification de la gestion locative<\/strong><\/li>\n\n\n\n<li><strong>Une meilleure visibilit\u00e9 sur le long terme<\/strong><\/li>\n<\/ul>\n\n\n\n<p>Toutefois, la pr\u00e9sence d\u2019un seul locataire implique \u00e9galement une concentration du risque locatif, un point \u00e0 consid\u00e9rer dans l\u2019analyse globale.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Une implantation aux Pays-Bas : un choix pertinent<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Un march\u00e9 dynamique en Europe<\/strong><\/h3>\n\n\n\n<p>Les Pays-Bas figurent parmi les march\u00e9s immobiliers les plus attractifs en Europe, notamment pour les actifs sp\u00e9cialis\u00e9s. La r\u00e9gion de Rotterdam se distingue par :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Une <strong>\u00e9conomie diversifi\u00e9e<\/strong><\/li>\n\n\n\n<li>Un acc\u00e8s facilit\u00e9 aux infrastructures logistiques et portuaires<\/li>\n\n\n\n<li>Une pr\u00e9sence croissante d\u2019acteurs dans les <strong>Life Sciences<\/strong><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Un environnement favorable \u00e0 l\u2019innovation<\/strong><\/h3>\n\n\n\n<p>Le pays b\u00e9n\u00e9ficie d\u2019un \u00e9cosyst\u00e8me favorable \u00e0 la recherche et au d\u00e9veloppement, avec :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Des <strong>universit\u00e9s reconnues<\/strong><\/li>\n\n\n\n<li>Des centres de recherche de niveau international<\/li>\n\n\n\n<li>Une politique publique soutenant l\u2019innovation<\/li>\n<\/ul>\n\n\n\n<p>Ce contexte peut permettre de renforcer l\u2019attractivit\u00e9 locative des actifs sp\u00e9cialis\u00e9s.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Analyse : quels enjeux pour la SCPI Com\u00e8te ?<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Un positionnement diff\u00e9renciant<\/strong><\/h3>\n\n\n\n<p>Avec cette acquisition, la SCPI Com\u00e8te adopte un positionnement qui se distingue de certaines SCPI plus traditionnelles. L\u2019int\u00e9gration d\u2019actifs <strong>Life Sciences<\/strong> peut permettre :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>D\u2019am\u00e9liorer la <strong>diversification sectorielle<\/strong><\/li>\n\n\n\n<li>De capter des tendances de fond li\u00e9es \u00e0 la sant\u00e9 et \u00e0 l\u2019innovation<\/li>\n\n\n\n<li>De renforcer le potentiel de valorisation du patrimoine<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Des points de vigilance \u00e0 consid\u00e9rer<\/strong><\/h3>\n\n\n\n<p>Malgr\u00e9 les atouts de cette op\u00e9ration, plusieurs \u00e9l\u00e9ments doivent \u00eatre pris en compte :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>La d\u00e9pendance \u00e0 un <strong>monolocataire<\/strong><\/li>\n\n\n\n<li>Les sp\u00e9cificit\u00e9s techniques des actifs Life Sciences, parfois plus complexes \u00e0 repositionner<\/li>\n\n\n\n<li>Les \u00e9volutions du march\u00e9 immobilier europ\u00e9en<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Comparaison avec les actifs immobiliers traditionnels<\/strong><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td class=\"has-text-align-center\" data-align=\"center\"><strong>Crit\u00e8res<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Life Sciences<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Bureaux classiques<\/strong><\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Dur\u00e9e des baux<\/td><td class=\"has-text-align-center\" data-align=\"center\">Longue<\/td><td class=\"has-text-align-center\" data-align=\"center\">Variable<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Typologie de locataires<\/td><td class=\"has-text-align-center\" data-align=\"center\">Sp\u00e9cialis\u00e9s (biotech, pharma)<\/td><td class=\"has-text-align-center\" data-align=\"center\">Diversifi\u00e9e<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Rendement potentiel<\/td><td class=\"has-text-align-center\" data-align=\"center\">Souvent attractif<\/td><td class=\"has-text-align-center\" data-align=\"center\">Plus standardis\u00e9<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Liquidit\u00e9<\/td><td class=\"has-text-align-center\" data-align=\"center\">Plus limit\u00e9e<\/td><td class=\"has-text-align-center\" data-align=\"center\">Plus \u00e9lev\u00e9e<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">R\u00e9silience sectorielle<\/td><td class=\"has-text-align-center\" data-align=\"center\">\u00c9lev\u00e9e<\/td><td class=\"has-text-align-center\" data-align=\"center\">D\u00e9pend du cycle \u00e9conomique<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Quel impact pour les investisseurs ?<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Une strat\u00e9gie orient\u00e9e long terme<\/strong><\/h3>\n\n\n\n<p>L\u2019int\u00e9gration d\u2019actifs Life Sciences dans un portefeuille SCPI peut permettre de viser :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Une <strong>stabilit\u00e9 des revenus<\/strong><\/li>\n\n\n\n<li>Une exposition \u00e0 un secteur porteur<\/li>\n\n\n\n<li>Une diversification internationale<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Un investissement \u00e0 appr\u00e9hender avec recul<\/strong><\/h3>\n\n\n\n<p>Comme tout placement immobilier, l\u2019investissement en SCPI comporte des risques :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Risque de perte en capital<\/strong><\/li>\n\n\n\n<li><strong>Risque de liquidit\u00e9<\/strong><\/li>\n\n\n\n<li><strong>Variabilit\u00e9 des performances<\/strong><\/li>\n<\/ul>\n\n\n\n<p>Une dur\u00e9e de d\u00e9tention longue, g\u00e9n\u00e9ralement sup\u00e9rieure \u00e0 <strong>8 ans<\/strong>, est souvent recommand\u00e9e pour lisser les cycles immobiliers.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Exemple concret d\u2019int\u00e9r\u00eat pour un investisseur<\/strong><\/h2>\n\n\n\n<p>Un investisseur souhaitant diversifier un portefeuille immobilier majoritairement expos\u00e9 aux bureaux pourrait int\u00e9grer une SCPI positionn\u00e9e sur les <strong>Life Sciences<\/strong>.<\/p>\n\n\n\n<p>Cela pourrait permettre :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>D\u2019acc\u00e9der \u00e0 un secteur innovant<\/li>\n\n\n\n<li>De r\u00e9partir les risques<\/li>\n\n\n\n<li>De b\u00e9n\u00e9ficier d\u2019une exposition europ\u00e9enne<\/li>\n<\/ul>\n\n\n\n<p>Par exemple, une allocation combinant :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>60 % bureaux<\/li>\n\n\n\n<li>20 % commerces<\/li>\n\n\n\n<li>20 % Life Sciences<\/li>\n<\/ul>\n\n\n\n<p>peut contribuer \u00e0 am\u00e9liorer la diversification globale.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Conclusion : une premi\u00e8re \u00e9tape structurante<\/strong><\/h2>\n\n\n\n<p>L\u2019acquisition de ce premier actif <strong>Life Sciences<\/strong> marque une \u00e9volution notable pour la SCPI Com\u00e8te. En s\u2019implantant aux Pays-Bas et en ciblant un secteur sp\u00e9cialis\u00e9, la strat\u00e9gie semble orient\u00e9e vers une <strong>diversification ma\u00eetris\u00e9e<\/strong> et une recherche d\u2019opportunit\u00e9s diff\u00e9renciantes.<\/p>\n\n\n\n<p>Cette op\u00e9ration illustre \u00e9galement une tendance de fond dans l\u2019univers des SCPI : l\u2019ouverture vers des classes d\u2019actifs alternatives, en phase avec les transformations \u00e9conomiques et soci\u00e9tales.<\/p>\n\n\n\n<p><strong>Avertissement : <\/strong><em>Les performances pass\u00e9es ne pr\u00e9jugent pas des performances futures.<\/em><\/p>\n\n\n\n<p>A lire \u00e9galement : <a href=\"https:\/\/www.rock-n-data.io\/fr\/scpi-coeur-d-avenir-une-dynamique-stable-au-t4-2025\/\">SCPI C\u0153ur d\u2019Avenir : 5 % de rendement en 2025<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Une premi\u00e8re acquisition strat\u00e9gique pour la SCPI Com\u00e8te La SCPI Com\u00e8te, g\u00e9r\u00e9e par Alderan, franchit une \u00e9tape importante dans son d\u00e9veloppement avec l\u2019acquisition de son premier actif de typologie Life Sciences. Situ\u00e9 \u00e0 proximit\u00e9 imm\u00e9diate de Rotterdam, cet immeuble illustre une volont\u00e9 claire de diversification sectorielle et g\u00e9ographique. Cette op\u00e9ration s\u2019inscrit dans une strat\u00e9gie d\u2019investissement [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":6970,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[74],"tags":[386,1340,22,1342,1339],"class_list":["post-6969","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investissement","tag-alderan","tag-investissement-scpi-pays-bas","tag-scpi-fr","tag-scpi-diversification-internationale","tag-scpi-life-sciences-europe","post-wrapper"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SCPI Com\u00e8te : 1er actif Life Sciences aux Pays-Bas \ud83c\uddf3\ud83c\uddf1<\/title>\n<meta name=\"description\" content=\"La SCPI Com\u00e8te acquiert un actif Life Sciences aux Pays-Bas, illustrant une strat\u00e9gie de diversification immobili\u00e8re en Europe.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SCPI Com\u00e8te : 1er actif Life Sciences aux Pays-Bas \ud83c\uddf3\ud83c\uddf1\" \/>\n<meta property=\"og:description\" content=\"La SCPI Com\u00e8te acquiert un actif Life Sciences aux Pays-Bas, illustrant une strat\u00e9gie de diversification immobili\u00e8re en Europe.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/\" \/>\n<meta property=\"og:site_name\" content=\"Rock &amp; DATA\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-07T15:03:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-07T15:03:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rock-n-data.io\/wp-content\/uploads\/2026\/04\/article-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"522\" \/>\n\t<meta property=\"og:image:height\" content=\"358\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Rock &amp; DATA\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rock &amp; DATA\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\\\/\"},\"author\":{\"name\":\"Rock &amp; DATA\",\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/#\\\/schema\\\/person\\\/9bc10987a0538f4580eb261ee8bb3257\"},\"headline\":\"SCPI Com\u00e8te : premier actif Life Sciences aux Pays-Bas\",\"datePublished\":\"2026-04-07T15:03:23+00:00\",\"dateModified\":\"2026-04-07T15:03:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\\\/\"},\"wordCount\":945,\"image\":{\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rock-n-data.io\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/article-1.jpg\",\"keywords\":[\"Alderan\",\"investissement SCPI Pays-Bas\",\"SCPI\",\"SCPI diversification internationale\",\"SCPI Life Sciences Europe\"],\"articleSection\":[\"Investissement\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\\\/\",\"url\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\\\/\",\"name\":\"SCPI Com\u00e8te : 1er actif Life Sciences aux Pays-Bas \ud83c\uddf3\ud83c\uddf1\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rock-n-data.io\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/article-1.jpg\",\"datePublished\":\"2026-04-07T15:03:23+00:00\",\"dateModified\":\"2026-04-07T15:03:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/#\\\/schema\\\/person\\\/9bc10987a0538f4580eb261ee8bb3257\"},\"description\":\"La SCPI Com\u00e8te acquiert un actif Life Sciences aux Pays-Bas, illustrant une strat\u00e9gie de diversification immobili\u00e8re en Europe.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rock-n-data.io\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/article-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rock-n-data.io\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/article-1.jpg\",\"width\":522,\"height\":358},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SCPI Com\u00e8te : premier actif Life Sciences aux Pays-Bas\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/\",\"name\":\"Rock &amp; DATA\",\"description\":\"When data meets commercial real estate investment\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/#\\\/schema\\\/person\\\/9bc10987a0538f4580eb261ee8bb3257\",\"name\":\"Rock &amp; DATA\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b94d4fc7b613a57715e272f17d430c39f49617a953e6b09d5da69b3774d096c0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b94d4fc7b613a57715e272f17d430c39f49617a953e6b09d5da69b3774d096c0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b94d4fc7b613a57715e272f17d430c39f49617a953e6b09d5da69b3774d096c0?s=96&d=mm&r=g\",\"caption\":\"Rock &amp; DATA\"},\"url\":\"https:\\\/\\\/www.rock-n-data.io\\\/fr\\\/author\\\/contact\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SCPI Com\u00e8te : 1er actif Life Sciences aux Pays-Bas \ud83c\uddf3\ud83c\uddf1","description":"La SCPI Com\u00e8te acquiert un actif Life Sciences aux Pays-Bas, illustrant une strat\u00e9gie de diversification immobili\u00e8re en Europe.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/","og_locale":"fr_FR","og_type":"article","og_title":"SCPI Com\u00e8te : 1er actif Life Sciences aux Pays-Bas \ud83c\uddf3\ud83c\uddf1","og_description":"La SCPI Com\u00e8te acquiert un actif Life Sciences aux Pays-Bas, illustrant une strat\u00e9gie de diversification immobili\u00e8re en Europe.","og_url":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/","og_site_name":"Rock &amp; DATA","article_published_time":"2026-04-07T15:03:23+00:00","article_modified_time":"2026-04-07T15:03:31+00:00","og_image":[{"width":522,"height":358,"url":"https:\/\/www.rock-n-data.io\/wp-content\/uploads\/2026\/04\/article-1.jpg","type":"image\/jpeg"}],"author":"Rock &amp; DATA","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Rock &amp; DATA","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/#article","isPartOf":{"@id":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/"},"author":{"name":"Rock &amp; DATA","@id":"https:\/\/www.rock-n-data.io\/fr\/#\/schema\/person\/9bc10987a0538f4580eb261ee8bb3257"},"headline":"SCPI Com\u00e8te : premier actif Life Sciences aux Pays-Bas","datePublished":"2026-04-07T15:03:23+00:00","dateModified":"2026-04-07T15:03:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/"},"wordCount":945,"image":{"@id":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rock-n-data.io\/wp-content\/uploads\/2026\/04\/article-1.jpg","keywords":["Alderan","investissement SCPI Pays-Bas","SCPI","SCPI diversification internationale","SCPI Life Sciences Europe"],"articleSection":["Investissement"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/","url":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/","name":"SCPI Com\u00e8te : 1er actif Life Sciences aux Pays-Bas \ud83c\uddf3\ud83c\uddf1","isPartOf":{"@id":"https:\/\/www.rock-n-data.io\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/#primaryimage"},"image":{"@id":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rock-n-data.io\/wp-content\/uploads\/2026\/04\/article-1.jpg","datePublished":"2026-04-07T15:03:23+00:00","dateModified":"2026-04-07T15:03:31+00:00","author":{"@id":"https:\/\/www.rock-n-data.io\/fr\/#\/schema\/person\/9bc10987a0538f4580eb261ee8bb3257"},"description":"La SCPI Com\u00e8te acquiert un actif Life Sciences aux Pays-Bas, illustrant une strat\u00e9gie de diversification immobili\u00e8re en Europe.","breadcrumb":{"@id":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/#primaryimage","url":"https:\/\/www.rock-n-data.io\/wp-content\/uploads\/2026\/04\/article-1.jpg","contentUrl":"https:\/\/www.rock-n-data.io\/wp-content\/uploads\/2026\/04\/article-1.jpg","width":522,"height":358},{"@type":"BreadcrumbList","@id":"https:\/\/www.rock-n-data.io\/fr\/scpi-comete-premier-actif-life-sciences-aux-pays-bas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rock-n-data.io\/fr\/"},{"@type":"ListItem","position":2,"name":"SCPI Com\u00e8te : premier actif Life Sciences aux Pays-Bas"}]},{"@type":"WebSite","@id":"https:\/\/www.rock-n-data.io\/fr\/#website","url":"https:\/\/www.rock-n-data.io\/fr\/","name":"Rock &amp; DATA","description":"When data meets commercial real estate investment","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rock-n-data.io\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.rock-n-data.io\/fr\/#\/schema\/person\/9bc10987a0538f4580eb261ee8bb3257","name":"Rock &amp; DATA","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/b94d4fc7b613a57715e272f17d430c39f49617a953e6b09d5da69b3774d096c0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b94d4fc7b613a57715e272f17d430c39f49617a953e6b09d5da69b3774d096c0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b94d4fc7b613a57715e272f17d430c39f49617a953e6b09d5da69b3774d096c0?s=96&d=mm&r=g","caption":"Rock &amp; DATA"},"url":"https:\/\/www.rock-n-data.io\/fr\/author\/contact\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rock-n-data.io\/fr\/wp-json\/wp\/v2\/posts\/6969","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rock-n-data.io\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rock-n-data.io\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rock-n-data.io\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rock-n-data.io\/fr\/wp-json\/wp\/v2\/comments?post=6969"}],"version-history":[{"count":0,"href":"https:\/\/www.rock-n-data.io\/fr\/wp-json\/wp\/v2\/posts\/6969\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rock-n-data.io\/fr\/wp-json\/wp\/v2\/media\/6970"}],"wp:attachment":[{"href":"https:\/\/www.rock-n-data.io\/fr\/wp-json\/wp\/v2\/media?parent=6969"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rock-n-data.io\/fr\/wp-json\/wp\/v2\/categories?post=6969"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rock-n-data.io\/fr\/wp-json\/wp\/v2\/tags?post=6969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}